Close

Industry Updates

EC grants marketing authorisation to Odefsey in HIV

Gilead Sciences, Inc announced that the EC hs granted marketing authorization for the once-daily single tablet regimen (STR) Odefsey®(emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg or R/F/TAF) for the treatment of HIV-1 infection in certain patients.  Odefsey combines...

Allergan Plc Receives FDA Approval for AVYCAZ sNDA

Allergan plc a leading global pharmaceutical company, announced the U.S. FDA has approved the company's supplemental New Drug Application (sNDA) to update the label for AVYCAZ® (ceftazidime and avibactam) with clinical data from a Phase 3 trial evaluating the...

St Jude Medical Expands Portfolio with New CRT Pacing Technology

St. Jude Medical Expands Its Heart Failure Portfolio with SyncAV CRT Technology, Providing Physicians Another Option for Managing Patients Not Responsive to Other Therapies. Adding SyncAV™ CRT technology to the company’s comprehensive heart failure offerings provides further advantages...

Key exhibitors and industry partners show strong support for MEDICAL MANUFACTURING ASIA 2016

3rd Manufacturing Processes for Medical Technology Exhibition and Conference sets the stage as the industry’s knowledge-information exchange platform Established as Asia’s leading exhibition for the medical technology, medical manufacturing processes and related sectors, MEDICAL MANUFACTURING ASIA 2016 modelled after COMPAMED...

Philips teams up with Visiopharm to boost breast cancer diagnosis objectivity through computational

Royal Philips announced that it has signed a licensing agreement with Visiopharm to offer their breast cancer panel software algorithms1 with Philips IntelliSite 2 digital pathology solution to help pathologists with an objective diagnosis of breast cancer. Applying smart computer...

Apollo Hospitals signs MOU with Hainan Ecological Smart City Group

Apollo Hospitals Group, India’s foremost integrated healthcare conglomerate and Hainan Ecological Smart City Group (HESCG), a Chinese industrial park development & operations company from the Hainan province of China, have signed an MoU to jointly develop a highly integrated...

Allergan plc announces data at ASM Microbe Highlight In Vitro Antimicrobial Activity of AVYCAZ

Allergan plc a leading global pharmaceutical company committed to developing new treatment options for infectious diseases, today presented new data highlighting the in vitro activity of AVYCAZ® (ceftazidime and avibactam) against several species of Gram-negative pathogens, including certain strains...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read